High expression of immunotherapy candidate proteins gp100, MART-1, tyrosinase and TRP-1 in uveal melanoma.

In the treatment of cutaneous melanoma, provisional therapeutic strategies have been designed to combat tumour load using T cells that are sensitized with peptides derived from melanoma autoantigens, such as glycoprotein 100 (gp100), melanoma antigen recognized by T cells 1 (MART-1 or MelanA), tyros...

Descripción completa

Detalles Bibliográficos
Autores principales: de Vries, T. J., Trancikova, D., Ruiter, D. J., van Muijen, G. N.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group|1 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063001/
https://www.ncbi.nlm.nih.gov/pubmed/9820172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063001/
https://www.ncbi.nlm.nih.gov/pubmed/9820172

Ejemplares similares